These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus. Shoukry A, Bdeer Sel-A, El-Sokkary RH. Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579 [Abstract] [Full Text] [Related]
4. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus. Wang QY, Chen FQ. Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668 [Abstract] [Full Text] [Related]
5. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy. Tam FW, Riser BL, Meeran K, Rambow J, Pusey CD, Frankel AH. Cytokine; 2009 Jul; 47(1):37-42. PubMed ID: 19409809 [Abstract] [Full Text] [Related]
6. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression]. Senatorski G, Paczek L, Kropiewnicka E, Bartłomiejczyk I. Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778 [Abstract] [Full Text] [Related]
7. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy. Ha SW, Kim HJ, Bae JS, Jeong GH, Chung SC, Kim JG, Park SH, Kim YL, Kam S, Kim IS, Kim BW. Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229 [Abstract] [Full Text] [Related]
8. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients. Takebayashi K, Matsumoto S, Aso Y, Inukai T. J Diabetes Complications; 2006 Aug; 20(2):98-104. PubMed ID: 16504838 [Abstract] [Full Text] [Related]
9. Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus. Ibrahim S, Rashed L. Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):911-7. PubMed ID: 18974575 [Abstract] [Full Text] [Related]
10. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy. Fujita H, Morii T, Koshimura J, Ishikawa M, Kato M, Miura T, Sasaki H, Narita T, Ito S, Kakei M. Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829 [Abstract] [Full Text] [Related]
12. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. Morii T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S. J Diabetes Complications; 2003 Dec; 17(1):11-5. PubMed ID: 12505750 [Abstract] [Full Text] [Related]
13. Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study. Verhave JC, Bouchard J, Goupil R, Pichette V, Brachemi S, Madore F, Troyanov S. Diabetes Res Clin Pract; 2013 Sep; 101(3):333-40. PubMed ID: 23880038 [Abstract] [Full Text] [Related]
14. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls. Tsapenko MV, Nwoko RE, Borland TM, Voskoboev NV, Pflueger A, Rule AD, Lieske JC. Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222 [Abstract] [Full Text] [Related]
15. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin. Wu C, Wang Q, Lv C, Qin N, Lei S, Yuan Q, Wang G. Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500 [Abstract] [Full Text] [Related]
16. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K. Kidney Int; 2000 Aug; 58(2):684-90. PubMed ID: 10916091 [Abstract] [Full Text] [Related]
17. [Change and significance of urinary smad3 in type 2 diabetic nephropathy]. Guo KF, Kou JX, Lu JX, Zhang L, Yu HY, Chen HB. Zhonghua Yi Xue Za Zhi; 2013 Apr 09; 93(14):1067-71. PubMed ID: 23902838 [Abstract] [Full Text] [Related]
18. Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy. Ye SD, Zheng M, Zhao LL, Qian Y, Yao XM, Ren A, Li SM, Jing CY. Eur J Clin Invest; 2009 Nov 09; 39(11):980-5. PubMed ID: 19663918 [Abstract] [Full Text] [Related]
19. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients. Navarro JF, Mora C, Muros M, García J. Nephrol Dial Transplant; 2006 Dec 09; 21(12):3428-34. PubMed ID: 16935891 [Abstract] [Full Text] [Related]
20. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases. Szeto CC, Chan RW, Lai KB, Szeto CY, Chow KM, Li PK, Lai FM. Nephrol Dial Transplant; 2005 Jan 09; 20(1):105-13. PubMed ID: 15561743 [Abstract] [Full Text] [Related] Page: [Next] [New Search]